A 14-year-old who underwent a lung transplant two years ago presents with a progressive decline in forced expiratory volume in 1 second (FEV1). After other causes are excluded, a diagnosis of bronchiolitis obliterans syndrome (BOS) is made. Which combination therapy has shown potential to halt the pulmonary progression of BOS?